We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Molecular Diagnostic Chip Targets Multidrug Resistant Tuberculosis

By LabMedica International staff writers
Posted on 29 Nov 2012
Print article
A multiplexed molecular diagnostic chip is capable of fast and accurate detection of Mycobacterium Tuberculosis Complex (MTBC) and its mutations, as well as nine other clinically important nontubercular Mycobacteria.

The newly launched Lab-on-Chip platform, marketed by Veredus Laboratories (Singapore) as the VerePLEX biosystem, combines Micro-Electro-Mechanical-Systems (MEMS) with microfluidics, to integrate multiplexed DNA amplification with microarray detection for rapid, cost-effective, and accurate analysis of biological materials.

The mutations in M. tuberculosis are responsible for its resistance to multiple drugs and for the global spread of Tuberculosis (TB). The rise of multidrug-resistant TB is a global healthcare challenge. Effective treatment of TB involves accurate and fast diagnosis followed by a strict regimen of the appropriate drugs. Shortcomings in this treatment can cause the TB organism to mutate into drug-resistant strains that can become increasingly difficult and expensive to treat.

Conventional methods of accurately identifying TB infections can take up to 8 weeks. In contrast, VereMTB can complete the diagnosis and identify the specific Mycobacterium causing the infection and drug resistance in less than 3 hours from natural samples, avoiding the need for culturing, the most time-consuming part of the traditional method. Additionally due to its compact size, the system can be deployed in a wide range of settings at point-of-need. “Natural samples” refer to direct sputum coughed out by TB patients.

The VereMTB chip is currently undergoing evaluations by the Chinese Center for Disease Control and Prevention (Beijing, China) as part of their ongoing program to assess new technologies for TB diagnostics. According to the 2012 World Health Organization report on TB, India and China combined have almost 40% of the world’s TB cases. Nearly 60% of multidrug resistant cases in 2011 were found in India, China, and the Russian Federation.

Related Links:

Veredus Laboratories


Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Automated Nucleic Acid Extraction Instrument
EX9600
New
Blood Culture Identification Fungal Pathogen Panel
cobas eplex BCID-FP panel

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: A scanning electron microscope image of chiral gold nanoparticles developed for a new microfluidic chip (Matter, 2024; DOI: 10.1016/j.matt.2024.09.005)

Simple Blood Draw Helps Diagnose Lung Cancer 10 Times Faster

Once dismissed as cellular waste, exosomes—tiny vesicles released by cells containing proteins, DNA, or RNA fragments—have emerged as vital players in cell-to-cell communication over the past decade.... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.